Clinical observation on palipeddone sustained release tablet in the treatment of schizophrenia

Dian Zhang Xiong, Yu Ru Yuan, Rong Gao, Qing Wang, Wen Pin Chang

Research output: Contribution to journalArticle

Abstract

Objective of this study was to evaluate the efficacy and adverse drug reactions (ADR) of palipeddone sustained release tablet in the treatment of schizophrenia in outpatients. Outpatients with schizophrenia treated with palipeddone sustained release tablet (observation group) in our hospital from Apr. to Sep. in 2009 were followed up and compared with those treated with risperidone (control group) during the same period. PANSS and TESS were applied to evaluate efficacy and ADR. Results suggest that the cure rates were 42.4% for control group and 49.6% for observation group. The effective rates were 74.8% for control group and 80.3% for observation group (P

Original languageEnglish
Pages (from-to)146-150
Number of pages5
JournalActivitas Nervosa Superior
Volume55
Issue number4
StatePublished - 2013

Fingerprint

Tablets
Schizophrenia
Observation
Drug-Related Side Effects and Adverse Reactions
Control Groups
Outpatients
Risperidone
Therapeutics

All Science Journal Classification (ASJC) codes

  • Psychiatry and Mental health
  • Clinical Neurology
  • Behavioral Neuroscience
  • Biological Psychiatry
  • Cognitive Neuroscience
  • Neurology

Cite this

Xiong, D. Z., Yuan, Y. R., Gao, R., Wang, Q., & Chang, W. P. (2013). Clinical observation on palipeddone sustained release tablet in the treatment of schizophrenia. Activitas Nervosa Superior, 55(4), 146-150.

Clinical observation on palipeddone sustained release tablet in the treatment of schizophrenia. / Xiong, Dian Zhang; Yuan, Yu Ru; Gao, Rong; Wang, Qing; Chang, Wen Pin.

In: Activitas Nervosa Superior, Vol. 55, No. 4, 2013, p. 146-150.

Research output: Contribution to journalArticle

Xiong, DZ, Yuan, YR, Gao, R, Wang, Q & Chang, WP 2013, 'Clinical observation on palipeddone sustained release tablet in the treatment of schizophrenia', Activitas Nervosa Superior, vol. 55, no. 4, pp. 146-150.
Xiong, Dian Zhang ; Yuan, Yu Ru ; Gao, Rong ; Wang, Qing ; Chang, Wen Pin. / Clinical observation on palipeddone sustained release tablet in the treatment of schizophrenia. In: Activitas Nervosa Superior. 2013 ; Vol. 55, No. 4. pp. 146-150.
@article{4a03437bb2e149b689ca94d70c9b3db8,
title = "Clinical observation on palipeddone sustained release tablet in the treatment of schizophrenia",
abstract = "Objective of this study was to evaluate the efficacy and adverse drug reactions (ADR) of palipeddone sustained release tablet in the treatment of schizophrenia in outpatients. Outpatients with schizophrenia treated with palipeddone sustained release tablet (observation group) in our hospital from Apr. to Sep. in 2009 were followed up and compared with those treated with risperidone (control group) during the same period. PANSS and TESS were applied to evaluate efficacy and ADR. Results suggest that the cure rates were 42.4{\%} for control group and 49.6{\%} for observation group. The effective rates were 74.8{\%} for control group and 80.3{\%} for observation group (P",
author = "Xiong, {Dian Zhang} and Yuan, {Yu Ru} and Rong Gao and Qing Wang and Chang, {Wen Pin}",
year = "2013",
language = "English",
volume = "55",
pages = "146--150",
journal = "Activitas Nervosa Superior",
issn = "1802-9698",
publisher = "Neuroscientia",
number = "4",

}

TY - JOUR

T1 - Clinical observation on palipeddone sustained release tablet in the treatment of schizophrenia

AU - Xiong, Dian Zhang

AU - Yuan, Yu Ru

AU - Gao, Rong

AU - Wang, Qing

AU - Chang, Wen Pin

PY - 2013

Y1 - 2013

N2 - Objective of this study was to evaluate the efficacy and adverse drug reactions (ADR) of palipeddone sustained release tablet in the treatment of schizophrenia in outpatients. Outpatients with schizophrenia treated with palipeddone sustained release tablet (observation group) in our hospital from Apr. to Sep. in 2009 were followed up and compared with those treated with risperidone (control group) during the same period. PANSS and TESS were applied to evaluate efficacy and ADR. Results suggest that the cure rates were 42.4% for control group and 49.6% for observation group. The effective rates were 74.8% for control group and 80.3% for observation group (P

AB - Objective of this study was to evaluate the efficacy and adverse drug reactions (ADR) of palipeddone sustained release tablet in the treatment of schizophrenia in outpatients. Outpatients with schizophrenia treated with palipeddone sustained release tablet (observation group) in our hospital from Apr. to Sep. in 2009 were followed up and compared with those treated with risperidone (control group) during the same period. PANSS and TESS were applied to evaluate efficacy and ADR. Results suggest that the cure rates were 42.4% for control group and 49.6% for observation group. The effective rates were 74.8% for control group and 80.3% for observation group (P

UR - http://www.scopus.com/inward/record.url?scp=84893483606&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84893483606&partnerID=8YFLogxK

M3 - Article

VL - 55

SP - 146

EP - 150

JO - Activitas Nervosa Superior

JF - Activitas Nervosa Superior

SN - 1802-9698

IS - 4

ER -